Harbin Treasure Pharmaceutical

Harbin Treasure Pharmaceutical, also known as Zhenbaodao Pharmaceutical, is a leading Chinese pharmaceutical company specializing in the research, development, manufacturing, and sale of Traditional Chinese Medicine (TCM), chemical drugs, and biological products. The company is particularly renowned for its cardiovascular and cerebrovascular treatments, with its flagship product Shuxuetong Injection being a major market leader in China. In recent years, the company has expanded its focus into modern biotechnology, including the development of monoclonal antibodies and small molecule inhibitors for oncology and other chronic diseases. Headquartered in Harbin, it operates multiple manufacturing bases and R&D centers across China and is listed on the Shanghai Stock Exchange. The company integrates a full industry chain from medicinal herb cultivation to high-tech pharmaceutical logistics.